A
Anika Therapeutics, Inc. (ANIK)
NMS – Real Time Price. Currency in USD
14.68
+0.14 (0.96%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
14.68
+0.14 (0.96%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.46 | 2.52 | 10 | |
| Quick ratio | 3.37 | 1.78 | 10 | |
| Debt to Equity | 0.19 | -0.80 | 9.0 | |
| Debt to Assets | 0.14 | 0.73 | 8.0 | |
| Interest coverage | N/A | -13.90 | 1.0 | |
| Weighted average score | 7.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 156M | 121M | 120M | 113M | 116M |
| Gross Profit | 94M | 83M | 76M | 64M | 68M |
| Operating Income | -19M | 844K | -5M | -11M | -12M |
| Net Income | -15M | -83M | -56M | -11M | -11M |
| EBITDA | -3M | 6M | 587K | -5M | -7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 3.53 | 38.46 | 7.0 |
| Next quarter | 5.4 | -112.5 | 3.0 |
| Current year | 5.14 | -209.09 | 3.0 |
| Next year | 6.72 | 229.17 | 7.5 |
| Weighted average score | 5.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -3.27 | -1831.5 | -12.89 | -257.35 | 1.0 |
| Y/Y | 13.16 | -3.75 | 550 | -112.48 | 5.0 |
| 3y average | -9.76 | -114.6 | 64.23 | 73.45 | 5.5 |
| 5y average | -2.05 | -137.19 | -31 | -9.14 | 1.0 |
| Weighted average score | 3.1 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $41.0M significantly exceed its total debt $25.7M, ensuring strong financial flexibility
Total current assets $93.6M exceed Total current liabilities $21.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (-0.8), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$6.3M limits the company's ability to reinvest or pay down debt